Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CGCNASDAQ:CRON On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$1.32-23.1%$1.28$0.77▼$8.68$241.78M0.795.81 million shs18.35 million shsCRONCronos Group$1.98-3.4%$1.87$1.60▼$2.61$763.11M1.061.30 million shs1.11 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth0.00%-28.14%-1.13%+6.05%-84.58%CRONCronos Group0.00%-2.46%+7.61%+0.51%-23.55%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCGCCanopy Growth2.1607 of 5 stars2.52.00.00.02.20.01.3CRONCronos Group1.905 of 5 stars0.05.00.00.04.20.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCGCCanopy Growth 1.00Sell$2.0052.09% UpsideCRONCronos Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CGC and CRON Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/30/2025CGCCanopy GrowthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderweight ➝ Underweight(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCGCCanopy Growth$276.75M0.87N/AN/A$2.72 per share0.48CRONCronos Group$124.59M6.12N/AN/A$2.87 per share0.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCGCCanopy Growth-$487.23M-$3.80N/AN/AN/A-156.98%-56.52%-24.18%8/7/2025 (Estimated)CRONCronos Group-$73.96M$0.13N/A66.001.74-42.65%-2.56%-2.47%8/14/2025 (Estimated)Latest CGC and CRON EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/30/2025Q4 2025CGCCanopy Growth-$0.28-$0.94-$0.66-$1.00$71.84 million$45.30 million5/8/2025Q1 2025CRONCronos Group$0.01$0.02+$0.01$0.02$45.44 million$33.62 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCGCCanopy GrowthN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCGCCanopy Growth0.743.522.58CRONCronos GroupN/A24.2423.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCGCCanopy Growth3.33%CRONCronos Group8.71%Insider OwnershipCompanyInsider OwnershipCGCCanopy Growth1.30%CRONCronos Group7.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCGCCanopy Growth3,150183.87 million153.39 millionOptionableCRONCronos Group450385.41 million356.14 millionOptionableCGC and CRON HeadlinesRecent News About These CompaniesCronos Group Inc. (NASDAQ:CRON) Shares Sold by Two Sigma Investments LPJune 1 at 3:59 AM | marketbeat.comTidal Investments LLC Decreases Stock Holdings in Cronos Group Inc. (NASDAQ:CRON)May 22, 2025 | marketbeat.comCronos Group: Industry Fortress Balance Sheet And FCF Create A Solid Upside PotentialMay 22, 2025 | seekingalpha.comTop Marijuana Stocks In A Volatile MarketMay 21, 2025 | marijuanastocks.comCronos Reports Improved Financials For Q1-2025 As Demand Outpaces SupplyMay 17, 2025 | seekingalpha.comShareholders Can Be Confident That Cronos Group's (TSE:CRON) Earnings Are High QualityMay 16, 2025 | finance.yahoo.comCronos Group Inc. (NASDAQ:CRON) Shares Purchased by Dimensional Fund Advisors LPMay 15, 2025 | marketbeat.comCronos Group (NASDAQ:CRON) Announces Earnings ResultsMay 12, 2025 | marketbeat.comCronos Group Inc. (NASDAQ:CRON) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comRaymond James Financial Inc. Takes $641,000 Position in Cronos Group Inc. (NASDAQ:CRON)May 10, 2025 | marketbeat.comTop 3 Marijuana Stocks For Better Investing 2025May 9, 2025 | marijuanastocks.comCronos Group Inc. (CRON) Q1 2025 Earnings Call TranscriptMay 8, 2025 | seekingalpha.comCronos Group Reports 2025 First Quarter ResultsMay 8, 2025 | globenewswire.comNews Explorer — 21Shares Introduces an ETP Tracking Cronos to Facilitate Investment in the Blockchain EcosystemMay 8, 2025 | decrypt.co21Shares Launches ETP Linked to Crypto.com's CronosMay 8, 2025 | coindesk.comCRO price forecast as 21Shares launches Cronos-linked ETPMay 8, 2025 | coinjournal.netRenaissance Technologies LLC Lowers Stock Holdings in Cronos Group Inc. (NASDAQ:CRON)May 4, 2025 | marketbeat.com3 Marijuana Stocks For The Long Term InvestingMay 2, 2025 | marijuanastocks.comCronos Group Inc. (CRON): Among the Best Tobacco and Cigarette Stocks to Buy NowApril 30, 2025 | msn.comCronos Group to Host Virtual 2025 Shareholders MeetingApril 28, 2025 | tipranks.comCronos Group Inc. to Hold Virtual 2025 Annual Meeting of ShareholdersApril 28, 2025 | financialpost.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCGC and CRON Company DescriptionsCanopy Growth NASDAQ:CGC$1.32 -0.40 (-23.10%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$1.32 +0.01 (+0.38%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.Cronos Group NASDAQ:CRON$1.98 -0.07 (-3.41%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$1.98 0.00 (0.00%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell Ackman Takes a Swing at Amazon — Should You? Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results? Intel’s Turnaround May Be the Best Bet No One’s Watching Apple’s Quiet HomePad Delay Could Be Its Loudest Move Yet Nike’s Amazon Expansion Could Signal a Turnaround in 2025 ASML Stock Might Be the Safest Chip Play at This Price Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
